Product Information

VERAPAMIL 80 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.0711 per EA under NDC 00591034301. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Oct 1, 1986. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VERAPAMIL 80 MG TABLET

Verapamil Hydrochloride
$0.0711per EA

Strength

80 mg/1

NDC

00591034301

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

VERAPAMIL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA070995

FDA Approved

10/1/1986

TE Code

AB

On Market Since

10/1/1986

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Cytochrome P450 3A4 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for VERAPAMIL 80 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 31.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0711 per EA
All-time high$0.0861 (Jul 15, 2026)
All-time low$0.0414 (Dec 19, 2018)
52-week high$0.0861
52-week low$0.0621
Median price$0.0525
Average price$0.0535
Largest weekly change+36.1% (Dec 23, 2015)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-4.7%

1M

-4.7%

3M

-11.4%

6M

+12.0%

1Y

+14.4%

3Y

+27.9%

5Y

+38.6%

All

+31.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of VERAPAMIL 80 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL 80 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.0711 per EA (NDC 00591034301), effective Aug 19, 2026.

How has the price of VERAPAMIL 80 MG TABLET changed over time?

Over the history we have for it, the NADAC for VERAPAMIL 80 MG TABLET has risen 31.3%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for VERAPAMIL 80 MG TABLET?

Since Nov 28, 2013, the NADAC for VERAPAMIL 80 MG TABLET has ranged from a low of $0.0414 (Dec 19, 2018) to a high of $0.0861 (Jul 15, 2026), with a median of $0.0525 per EA.

Are there cheaper alternatives to VERAPAMIL 80 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VERAPAMIL 80 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures VERAPAMIL 80 MG TABLET?

VERAPAMIL 80 MG TABLET (NDC 00591034301) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.